isotretinoin and Somatoform-Disorders

Acne is one of the most common concerns of patients with body dysmorphic disorder (BDD), a psychiatric condition defined as a preoccupation with a slight or imagined defect in appearance that causes significant disruption in daily functioning.. We sought to screen for BDD symptoms among patients with acne across a spectrum of acne severity.. We used a validated self-report questionnaire and an objective assessment of acne severity by a single observer.. Rates of BDD ranged from 14.1% using more stringent criteria to assess acne severity to 21.1% using less stringent criteria. Two-fold increased odds of having BDD was seen in patients requiring systemic isotretinoin therapy.. Cross-sectional study design is a limitation.. A significant proportion of patients, regardless of their acne severity at the time of examination, have substantial distress and preoccupation related to their facial appearance.

Topics: Acne Vulgaris; Adolescent; Adult; Cross-Sectional Studies; Female; Humans; Incidence; Isotretinoin; Male; Prevalence; Severity of Illness Index; Somatoform Disorders; Surveys and Questionnaires

Topics: Acne Vulgaris; Adult; Dermatologic Agents; Humans; Isotretinoin; Male; Social Isolation; Somatoform Disorders; Twins